Advertisement

Topics

Black Diamond Therapeutics raises $85M in Series B funding

08:33 EST 11 Jan 2019 | MedCity News

Money currency vector illustration. Various money bills dollar cash paper bank notes and gold coins. Collection of cash heap pile and currency stack vector set.

The raise comes a month after the Cambridge, Massachusetts-based firm’s launch with a $20 million Series A round. Black Diamond is developing drugs that target allosteric mutant oncogenes, which it describes as an unexplored space.

Original Article: Black Diamond Therapeutics raises $85M in Series B funding

NEXT ARTICLE

More From BioPortfolio on "Black Diamond Therapeutics raises $85M in Series B funding"

Advertisement
Quick Search
Advertisement
Advertisement